Key facts
| Price (PPV) | 180.20 MAD |
|---|---|
| Dispensing status | Schedule A — prescription only |
| Composition (DCI) | amlodipinevalsartanhydrochlorothiazide |
| Class | Agents acting on the renin-angiotensin system |
| ATC code | C09DX01 |
| Manufacturer | PHI |
| Presentation | Boite de 28 |
| Hospital price | 112.60 MAD |
| Data collected on | 9/8/2026 |
Find an open pharmacy
On-call pharmacies near you
Same-strength alternatives — cheapest first
Suliat HCT 10 mg / 160 mg / 12.5 mg (AFRIC-PHAR) contains the same active substance as Exvals Plus 10 mg / 160 mg / 25 mg (Amlodipine | Valsartan | Hydrochlorothiazide) at the same strength, but in a different pack: Boite de 14 at 105.20 MAD, i.e. 7.51 MAD per unit against 6.44 MAD for Exvals Plus 10 mg / 160 mg / 25 mg. The public sale price is set by the Ministry of Health: it is identical in every pharmacy.
Same pack size
| Product | Manufacturer | Pack | PPV | Unit price | Difference |
|---|---|---|---|---|---|
| Exvals Plus 10 mg / 160 mg / 12.5 mg | PHI | Boite de 28 | 180.20 MAD | 6.44 / unit | — |
| Suliat HCT 10 mg / 160 mg / 25 mg | AFRIC-PHAR | Boite de 28 | 185.20 MAD | 6.61 / unit | — |
| Suliat HCT 10 mg / 160 mg / 12.5 mg | AFRIC-PHAR | Boite de 28 | 185.20 MAD | 6.61 / unit | — |
Other pack sizes
| Product | Manufacturer | Pack | PPV | Unit price |
|---|---|---|---|---|
| Suliat HCT 10 mg / 160 mg / 12.5 mg | AFRIC-PHAR | Boite de 14 | 105.20 MAD | 7.51 / unit |
| Suliat HCT 10 mg / 160 mg / 25 mg | AFRIC-PHAR | Boite de 14 | 105.20 MAD | 7.51 / unit |
| Suliat HCT 10 mg / 160 mg / 12.5 mg | AFRIC-PHAR | Boite de 56 | 306 MAD | 5.46 / unit |
| Suliat HCT 10 mg / 160 mg / 25 mg | AFRIC-PHAR | Boite de 56 | 306 MAD | 5.46 / unit |
Substituting a generic is the pharmacist's decision; for medicines listed in schedules A, B and C it still requires a prescription. Public sale prices published by the Directorate of Medicines and Pharmacy, recorded on 9/8/2026.
About Exvals Plus 10 mg / 160 mg / 25 mg
Exvals Plus 10 mg / 160 mg / 25 mg belongs to the agents acting on the renin-angiotensin system therapeutic class. In Morocco, this drug is marketed by PHI and is among the pharmaceutical specialties referenced by the Ministry of Health.
For any question about the use, effects, or drug interactions of Exvals Plus 10 mg / 160 mg / 25 mg, consult your doctor or pharmacist. This information is provided for educational purposes and does not replace medical advice.
Frequently Asked Questions about Exvals Plus 10 mg / 160 mg / 25 mg
Answers to common questions from Moroccan patients about this drug.